These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25526583)

  • 21. Effects of exposure to quaternary-ammonium-based biocides on antimicrobial susceptibility and tolerance to physical stresses in bacteria from organic foods.
    Gadea R; Fernández Fuentes MÁ; Pérez Pulido R; Gálvez A; Ortega E
    Food Microbiol; 2017 May; 63():58-71. PubMed ID: 28040182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial efficacy of disinfectants against some gramnegative bacteria.
    Majtán V; Majtánová L
    Cent Eur J Public Health; 2002 Sep; 10(3):104-6. PubMed ID: 12298340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptation of Pseudomonas aeruginosa clinical isolates to benzalkonium chloride retards its growth and enhances biofilm production.
    El-Banna T; Abd El-Aziz A; Sonbol F; El-Ekhnawy E
    Mol Biol Rep; 2019 Jun; 46(3):3437-3443. PubMed ID: 30972606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.
    Epstein SP; Bottone EJ; Asbell PA
    Eye Contact Lens; 2006 Sep; 32(5):240-4. PubMed ID: 16974157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tris-EDTA significantly enhances antibiotic efficacy against multidrug-resistant Pseudomonas aeruginosa in vitro.
    Buckley LM; McEwan NA; Nuttall T
    Vet Dermatol; 2013 Oct; 24(5):519-e122. PubMed ID: 24025021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates.
    Cabassi CS; Sala A; Santospirito D; Alborali GL; Carretto E; Ghibaudo G; Taddei S
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):17. PubMed ID: 28335779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of antibiotic and disinfectant susceptibility profiles among Pseudomonas aeruginosa veterinary isolates recovered during 1994-2003.
    Beier RC; Foley SL; Davidson MK; White DG; McDermott PF; Bodeis-Jones S; Zhao S; Andrews K; Crippen TL; Sheffield CL; Poole TL; Anderson RC; Nisbet DJ
    J Appl Microbiol; 2015 Feb; 118(2):326-42. PubMed ID: 25431276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
    Joly-Guillou ML; Bergogne-Berezin E; Verin-Prevost C
    Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).
    Sader HS; Farrell DJ; Castanheira M; Flamm RK; Jones RN
    J Antimicrob Chemother; 2014 Oct; 69(10):2713-22. PubMed ID: 24917579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa.
    Pepeljnjak S; Kosalec I
    FEMS Microbiol Lett; 2004 Nov; 240(1):111-6. PubMed ID: 15500987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
    Denis C; Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
    Pathol Biol (Paris); 1984 May; 32(5):415-20. PubMed ID: 6429614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial effects of water soluble green tea extracts on multi-antibiotic resistant isolates of Pseudomonas aeruginosa.
    Jazani NH; Shahabi Sh; Ali AA
    Pak J Biol Sci; 2007 May; 10(9):1544-6. PubMed ID: 19069973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudomonas aeruginosa cells adapted to benzalkonium chloride show resistance to other membrane-active agents but not to clinically relevant antibiotics.
    Loughlin MF; Jones MV; Lambert PA
    J Antimicrob Chemother; 2002 Apr; 49(4):631-9. PubMed ID: 11909837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of higher minimum inhibitory concentrations of quaternary ammonium compounds in clinical E. coli isolates on antibiotic susceptibilities and clinical outcomes.
    Buffet-Bataillon S; Branger B; Cormier M; Bonnaure-Mallet M; Jolivet-Gougeon A
    J Hosp Infect; 2011 Oct; 79(2):141-6. PubMed ID: 21807440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents.
    Fujimura T; Anan N; Sugimori G; Watanabe T; Jinushi Y; Yoshida I; Yamano Y
    Int J Antimicrob Agents; 2009 Dec; 34(6):523-8. PubMed ID: 19748767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
    Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
    Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.